Ripretinib for the treatment of advanced gastrointestinal stromal tumor

por Zalcberg, John R.
Publicado 2021

Clinical utility of ramucirumab in advanced gastric cancer

por Chan, Matthew MK, Sjoquist, Katrin M, Zalcberg, John R
Publicado 2015

Non-aspirin non-steroidal anti-inflammatory drugs in colorectal cancer: a review of clinical studies

por Zaman, Farzana Y., Orchard, Suzanne G., Haydon, Andrew, Zalcberg, John R.
Publicado 2022

A critical review of the role of Fc gamma receptor polymorphisms in the response to monoclonal antibodies in cancer

por Mellor, James D, Brown, Michael P, Irving, Helen R, Zalcberg, John R, Dobrovic, Alexander
Publicado 2013

Functional Decline in the Cancer Patient: A Review

por Muhandiramge, Jaidyn, Orchard, Suzanne G., Warner, Erica T., van Londen, Gijsberta J., Zalcberg, John R.
Publicado 2022

Developing an Australian multi-module clinical quality registry for gynaecological cancers: a protocol paper

por Heriot, Natalie, Brand, Alison, Cohen, Paul, Hegarty, Sue, Hyde, Simon, Leung, Yee, Zalcberg, John R, Rome, Robert
Publicado 2020

Cardiovascular Disease in Adult Cancer Survivors: a Review of Current Evidence, Strategies for Prevention and Management, and Future Directions for Cardio-oncology

por Muhandiramge, Jaidyn, Zalcberg, John R., van Londen, G. J., Warner, Erica T., Carr, Prudence R., Haydon, Andrew, Orchard, Suzanne G.
Publicado 2022

Real-world treatment patterns, healthcare resource use and clinical outcomes of patients receiving second line therapy for advanced or metastatic gastric cancer

por Gómez-Ulloa, David, Amonkar, Mayur, Kothari, Smita, Cheung, Winson Y., Chau, Ian, Zalcberg, John R., Lara Suriñach, Núria, Falcone, Alfredo
Publicado 2020

A snapshot of consumer engagement in clinical trials in Australia: results of a national survey of clinical trial networks and research organisations

por McKenzie, Anne, Bowden, Janelle, Zalcberg, John R., Conroy, Karena, Fallon-Ferguson, Julia, Jesudason, Shilpanjali, Ansell, James, Anderst, Ania, Straiton, Nicola
Publicado 2022

Landscape of clinical trials across the pancreatic cancer care continuum: an Australian perspective

por Khan, Nadia N, Basrai, Harleen, Evans, Sue M, Ioannou, Liane J, Pilgrim, Charles HC, Zalcberg, John R, Jones, Gayle M, Hanson, Susan
Publicado 2022

Characteristics of patients diagnosed with pancreatic cancer who access palliative care: An observational study

por Khan, Nadia N., Evans, Sue M., Ioannou, Liane J., Pilgrim, Charles H. C., Blanchard, Megan, Daveson, Barbara, Philip, Jennifer, Zalcberg, John R., te Marvelde, Luc
Publicado 2023

What matters most to patients following percutaneous coronary interventions? A new patient-reported outcome measure developed using Rasch analysis

por Soh, Sze-Ee, Barker, Anna L., Ayton, Darshini R., Ahern, Susannah, Morello, Renata, Lefkovits, Jeffrey, Brennan, Angela L., Evans, Susan, Zalcberg, John R., Reid, Christopher M., McNeil, John J.
Publicado 2019

Colon and rectal cancer treatment patterns and their associations with clinical, sociodemographic and lifestyle characteristics: analysis of the Australian 45 and Up Study cohort

por Yap, Sarsha, He, Emily, Egger, Sam, Goldsbury, David E, Lew, Jie-Bin, Ngo, Preston J, Worthington, Joachim, Rillstone, Hannah, Zalcberg, John R, Cuff, Jeff, Ward, Robyn L, Canfell, Karen, Feletto, Eleonora, Steinberg, Julia
Publicado 2023

Updated cost-effectiveness analysis of lung cancer screening for Australia, capturing differences in the health economic impact of NELSON and NLST outcomes

por Behar Harpaz, Silvia, Weber, Marianne F., Wade, Stephen, Ngo, Preston J., Vaneckova, Pavla, Sarich, Peter E. A., Cressman, Sonya, Tammemagi, Martin C., Fong, Kwun, Marshall, Henry, McWilliams, Annette, Zalcberg, John R., Caruana, Michael, Canfell, Karen
Publicado 2022

Cancer Treatment Patterns and Factors Affecting Receipt of Treatment in Older Adults: Results from the ASPREE Cancer Treatment Substudy (ACTS)

por Muhandiramge, Jaidyn, Warner, Erica T., Zalcberg, John R., Haydon, Andrew, Polekhina, Galina, van Londen, Gijsberta J., Gibbs, Peter, Bernstein, Wendy B., Tie, Jeanne, Millar, Jeremy L., Mar, Victoria J., McNeil, John J., Woods, Robyn L., Orchard, Suzanne G.
Publicado 2023

Clinical Activity of Ripretinib in Patients with Advanced Gastrointestinal Stromal Tumor Harboring Heterogeneous KIT/PDGFRA Mutations in the Phase III INVICTUS Study

por Bauer, Sebastian, Heinrich, Michael C., George, Suzanne, Zalcberg, John R., Serrano, César, Gelderblom, Hans, Jones, Robin L., Attia, Steven, D'Amato, Gina, Chi, Ping, Reichardt, Peter, Meade, Julie, Su, Ying, Ruiz-Soto, Rodrigo, Blay, Jean-Yves, von Mehren, Margaret, Schöffski, Patrick
Publicado 2021

Patient-reported outcomes in individuals with advanced gastrointestinal stromal tumor treated with ripretinib in the fourth-line setting: analysis from the phase 3 INVICTUS trial

por Schöffski, Patrick, George, Suzanne, Heinrich, Michael C., Zalcberg, John R., Bauer, Sebastian, Gelderblom, Hans, Serrano, César, Jones, Robin L., Attia, Steven, D’Amato, Gina, Chi, Ping, Reichardt, Peter, Becker, Claus, Shi, Kelvin, Meade, Julie, Ruiz-Soto, Rodrigo, Blay, Jean-Yves, von Mehren, Margaret
Publicado 2022

Barriers and enablers to the implementation of protocol-based imaging in pancreatic cancer: A qualitative study using the theoretical domains framework

por Maharaj, Ashika D., Evans, Sue M., Zalcberg, John R., Ioannou, Liane J., Graco, Marnie, Croagh, Daniel, Pilgrim, Charles H. C., Dodson, Theresa, Goldstein, David, Philip, Jennifer, Kench, James G., Merrett, Neil D., Neale, Rachel E., White, Kate, Evans, Peter, Leong, Trevor, Green, Sally E.
Publicado 2020

Clinical Benefit of Ripretinib Dose Escalation After Disease Progression in Advanced Gastrointestinal Stromal Tumor: An Analysis of the INVICTUS Study

por Zalcberg, John R., Heinrich, Michael C., George, Suzanne, Bauer, Sebastian, Schöffski, Patrick, Serrano, César, Gelderblom, Hans, Jones, Robin L., Attia, Steven, D'Amato, Gina, Chi, Ping, Reichardt, Peter, Somaiah, Neeta, Meade, Julie, Reichert, Vienna, Shi, Kelvin, Sherman, Matthew L., Ruiz‐Soto, Rodrigo, von Mehren, Margaret, Blay, Jean‐Yves
Publicado 2021

Ripretinib Versus Sunitinib in Patients With Advanced Gastrointestinal Stromal Tumor After Treatment With Imatinib (INTRIGUE): A Randomized, Open-Label, Phase III Trial

por Bauer, Sebastian, Jones, Robin L., Blay, Jean-Yves, Gelderblom, Hans, George, Suzanne, Schöffski, Patrick, von Mehren, Margaret, Zalcberg, John R., Kang, Yoon-Koo, Razak, Albiruni Abdul, Trent, Jonathan, Attia, Steven, Le Cesne, Axel, Su, Ying, Meade, Julie, Wang, Tao, Sherman, Matthew L., Ruiz-Soto, Rodrigo, Heinrich, Michael C.
Publicado 2022